Notice NOT-MD-20-024 from the NIH Guide for Grants and Contracts

Secondary experience areas of interest include medical image data analysis, genome assembly, variant or copy number variation detection, ChIP-seq, and other…
From University of Wisconsin–Madison - Tue, 16 Jun 2020 00:57:22 GMT - View all Madison, WI jobs

£37,398 to £44,798 dependent on experience: Wellcome Sanger Institute: Seeking a motivated and experienced scientist in cancer molecular biology and genetics to lead the expansion and curation of the Cancer Gene Census. Hinxton, Saffron Walden, Essex

Competitive Salary: EMBL: Data Scientist in Computational Biology Location: Germany (DE)

Funding Opportunity PAR-20-235 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages research to develop task-based behavioral measures that are shown to engage brain systems relevant to anhedonia using neuroimaging or other brain measures with similar spatial resolution. The goal is to identify behavioral tasks that can be used as quantitative tools in future studies of the functional constructs associated with anhedonia and in treatment development. This Funding Opportunity Announcement is for basic science experimental studies involving human participants that fall within the NIH definition of a clinical trial and also meet the definition of basic research. Types of studies that should submit under this FOA include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical or behavioral outcomes in humans for the purpose of understanding the fundamental aspects of brain function in healthy individuals or those with disorders. These mechanistic studies are expected to be responsive to the BESH FOAs https://grants.nih.gov/grants/guide/notice-files/NOT-MH-19-006.html since they are not intended to inform on the improvement of the health status of the individual or a group of individuals either by better understanding the mechanism of action of an intervention or a measurable improvement in health.

Notice NOT-TR-20-029 from the NIH Guide for Grants and Contracts

Notice NOT-HL-20-797 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-20-234 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated multi-site clinical trials (all phases or stages) of interventions focused on specific aging-related issues to reducing transmission, risk, morbidity, mortality, severity, or complications of Coronavirus Disease 2019 (COVID-19).

Funding Opportunity RFA-AI-20-036 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is soliciting applications to support research on HIV cure in pediatric populations. This FOA will support coordinated basic, clinical, and applied research focused on developing strategies to achieve an HIV cure, defined as either sustained viral remission or eradication of HIV infection. The cure of HIV infection in people living with HIV (PLWH) is one of the highest priorities of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). The goal of the Martin Delaney Collaboratory program is to accelerate progress towards developing strategies to achieve either eradication of HIV infection from the body or a sustained viral remission, as defined by sustained viral suppression following cessation of antiretroviral therapy. Funded projects under this FOA will be expected to expand the knowledge base on HIV latency and persistence in pediatric populations, design and evaluate innovative cure strategies, develop and evaluate assays and other modalities to accurately characterize HIV reservoirs and translate findings to the clinical settings. This funding opportunity will target perinatally infected children and adolescents up to 24 years of age with a primary focus on early treated children.

Funding Opportunity RFA-AI-20-035 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to address the problem of HIV persistence in people living with HIV treated with suppressive antiretroviral drug regimens. This FOA will support coordinated basic, clinical, and applied research focused on developing strategies to achieve an HIV cure, defined as either sustained viral remission or eradication of HIV infection. While some aspect of clinical research is required, unlike the previous iteration of this RFA, clinical trials will no longer be supported. The application must include at least one private sector entity to facilitate rapid translation of basic discovery research into therapeutic development and testing. Collaboratory research should be milestone-based and should be focused on specific innovative approaches to characterize and quantify persistent HIV-1 reservoirs and/or understand and predict post-treatment control of viral rebound, identify and test therapeutic strategies to control viral rebound after discontinuation of antiretroviral therapy, and identify and test strategies to eradicate or permanently inactivate rebound-competent HIV.

Funding Opportunity RFA-AG-21-023 from the NIH Guide for Grants and Contracts. The goal of the GEMSSTAR program is to provide support for early-career physician-scientists trained in medical or surgical specialties or early-career dentist-scientists to launch careers as future leaders in aging- or geriatric-focused research. To achieve this goal, the GEMSSTAR Funding Opportunity Announcement (FOA) provides small grants to conduct transdisciplinary aging research that will yield pilot data and experience for subsequent aging research projects.

Funding Opportunity RFA-HL-21-001 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support hybrid effectiveness-implementation trials for heart, lung, blood, and sleep (HLBS) diseases in the inpatient setting. NHLBI is seeking applications that propose a trial testing an implementation strategy (or strategies) that was developed utilizing an implementation research framework and that aims to increase implementation of an evidence-based practice(s). This FOA intends to support applications that propose a multidisciplinary research team that includes expertise in inpatient clinical research, implementation research, and biostatistics. Any applicant proposing a trial that meets the requirements of this FOA is eligible to apply, regardless of participation in Planning Hybrid Effectiveness-Implementation Trials for Heart, Lung, Blood, and Sleep Diseases in the Inpatient Setting (U34) (RFA-HL-18-018).

Notice NOT-MH-20-055 from the NIH Guide for Grants and Contracts

Bachelor Degree in a Computer Science or Engineering related area Experience: Understanding of Molecular Biology, Bioinformatics, or related field of biology is…
From Covance - Sat, 13 Jun 2020 01:32:45 GMT - View all Redmond, WA jobs

Notice NOT-HD-20-018 from the NIH Guide for Grants and Contracts

Notice NOT-HL-20-796 from the NIH Guide for Grants and Contracts

Competitive Salary: EMBL: Scientific Project Manager Location: Cambridge, Cambridgeshire, England

Competitive Salary: EMBL: GWAS Catalog Technical Project Lead Location: Cambridge, Cambridgeshire, England

Notice NOT-OD-20-121 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-120 from the NIH Guide for Grants and Contracts